NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-174-2011-0-EP-17 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes EP DIV 17163568.3 Issued
NCI E-174-2011-0-GB-27 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes GB EP 17163568.3 Issued
NCI E-174-2011-0-FR-26 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes FR EP 17163568.3 Issued
NCI E-174-2011-0-DE-25 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes DE EP 17163568.3 Issued
NCI E-174-2011-0-EP-07 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes EP National Stage 12727074.2 Issued
NCI E-174-2011-0-KR-10 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes KR National Stage 10-2013-7032402 Abandoned
NCI E-174-2011-0-JP-09 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes JP National Stage 2014-514616 Issued
NCI E-174-2011-0-AU-03 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes AU National Stage 2012268013 Issued
NCI E-174-2011-0-PCT-02 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes PCT PCT PCT/US2012/041234 Expired
NCI E-081-2015-0-US-01 HUMAN BISPECIFIC EGFRVIII ANTIBODY ENGAGING MOLECULES US 61/656,717 Abandoned
NIA E-158-2012-2-US-01 Use of Erythropoietin And Derivatives For Treating Hypertension. US 61/656,698 Abandoned
NCATS E-203-2012-0-US-01 METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1 US 61/656,806 Abandoned
NCI E-174-2011-0-BR-04 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes BR National Stage BR112013031262-9 Abandoned
NIDDK E-248-2004-0-JP-13 PURINE DERIVATIVES AS A3 AND A1 ADENOSINE RECEPTOR AGONISTS JP DIV 2012-128779 Abandoned
NCI E-269-2011-0-US-01 Kits For Detecting And Monitoring Endocrine Disrupting Chemicals (EDCs) US 61/656,473 Abandoned
NIAID E-109-2007-1-US-04 Detection Of Infectious Prion Protein By Seeded Conversion Of Recombinant Prion Protein US CON 13/489,321 Abandoned
NHLBI E-291-2009-0-US-03 Hydrazone And Diacyl Hydrazine Compounds And Methods Of Use US National Stage 13/513,819 8518968 Issued PDF
NCI E-025-2010-0-US-06 Diazeniumdiolated Compounds, Pharmaceutical Compositions, and Method of Treating Cancer US National Stage 13/509,431 9205091 Issued PDF
NCI E-136-2012-0-US-01 High-affinity Monoclonal Antibodies To Glypican-3 And Use Thereof US 61/654,232 Abandoned
NHLBI E-292-2009-0-US-03 Signal-to-noise Enhancement In Imaging Applications Using A Time-Series of Images US National Stage 13/513,150 8942454 Issued PDF
NCI E-133-2009-0-US-03 Nitroxide Therapy For The Treatment Of Von Hippel-Lindau Disease (VHL) And Renal Clear Cell Carcinoma (RCC) US National Stage 13/512,665 8853277 Issued PDF
NCI E-059-2007-2-US-06 GP100-Specific T Cell Receptors And Related Materials and Methods of Use US DIV 13/483,286 8613932 Abandoned PDF
NCI E-207-2008-0-US-03 Dual Specific Immunotoxin for Brain Tumor Therapy US CON 13/482,406 Abandoned
NIDDK E-194-2012-0-US-01 Eukaryotic Transposase Mutants And Transposon End Compositions For Modifying Nucleic Acids And Methods For Production And Use In The Generation Of Sequencing Libraries US 61/652,560 Abandoned
NIMH E-274-2015-0-US-03 Compositions and Methods for Treating Bladder Cancer US National Stage 13/502,132 9321820 Issued PDF
NIAID E-252-2012-0-PCT-02 Kunitz Inhibitor Of Proteases PCT PCT PCT/US2012/039585 Expired
NCI E-293-2010-0-PCT-02 Lipopeptide Inhibitors Of RAS Oncoproteins PCT PCT PCT/US12/39623 Expired
NIA E-139-2012-0-US-01 METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES US 61/651,961 Abandoned
NIDDK E-285-2008-1-US-01 Adenosine Receptor Agonists, Partial Agonists, and Antagonists US CIP 13/479,973 9181253 Issued PDF
NIAID E-154-2011-3-PCT-01 METHOD FOR INDUCING AN IMMUNE RESPONSE AND FORMULATIONS THEREOF PCT PCT COMB PCT/US2012/039473 Expired
NCI E-082-2014-0-PCT-02 ALCOHOL-, DIOL-, AND CARBOHYDRATE-SUBSTITUTED INDENOISOQUINOLINES AS TOPOISOMERASE I INHIBITORS PCT PCT PCT/US2012/039365 Expired
NINDS E-206-2011-3-PCT-01 USE OF PHOSPHATASE INHIBITORS OR HISTONE DEACETYLASE INHIBITORS TO TREAT DISEASES CHARACTERIZED BY LOSS OF PROTEIN FUNCTION PCT PCT COMB PCT/US2012/039405 Expired
NIDCR E-015-2002-3-JP-10 MAMMALIAN SWEET AND AMINO ACID HETERODIMERIC TASTE RECEPTORS JP DIV 2011-116399 Abandoned
NIAID E-117-2006-0-US-08 BORIS Isoforms And Methods of Detecting And Treating Disease US DIV 13/478,779 8440415 Issued PDF
NIAID E-186-2011-1-PCT-01 Prime-Boost Vaccination For Viral Infection PCT PCT COMB PCT/US2012/039197 Expired
NCI E-105-2012-0-US-01 Murine Anti-NY-ESO-1 T Cell Receptors US 61/650,020 Abandoned
NINDS E-143-2002-1-US-15 METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS US CON 13/475,688 Abandoned
NHGRI E-187-2011-0-US-02 Methods For Detecting ADHD Susceptibility And Predicting Severity Ans Long Term Outcome of ADHD Symptoms US ORD 13/475,342 Abandoned
NCI E-164-2012-0-US-01 Nanoparticles With Enhanced Entry Into Cancer Cells US 61/648,735 Abandoned
CC E-267-2011-0-US-01 Whole Heart Extracellular Volume Fraction/Volume Of Distribution By Low Dose Computed Tomography US 61/648,996 Abandoned
NIAID E-140-2012-0-US-01 HIV-Neutralizing Polypeptides And Methods Of Their Use. US 61/649,150 Abandoned
NCI E-246-2003-1-US-09 Non-Peptide Antagonists Of Gastrin Releasing Peptide US DIV 13/473,507 Abandoned
NIAMS E-116-2005-0-US-04 Tissue Engineered Cartilage, Methods of Making Same, Theuraputics and Cosmetic Surgical Application Using Same US DIV 13/472,173 Abandoned
NIEHS E-080-2012-0-US-01 Use Of Antagonists Of Hyaluronan Signaling For Treatment Of Airway Inflammation And Hyperresponsiveness US 61/647,101 Abandoned
NCI E-014-2007-0-US-23 Smoothened Polypeptides And Methods Of Use US DIV 13/470,965 8546524 Abandoned PDF
NCI E-025-2010-0-EP-05 Diazeniumdiolated Compounds, Pharmaceutical Compositions, And Method of Treating Cancer EP National Stage 10778814.3 Abandoned
NCI E-273-2011-0-US-01 Cross Reactive Antibodies Against Dengue Virus And Uses Thereof US 61/646,638 Abandoned
NIA E-103-2011-2-EP-05 USE OF ZSCAN4 AND ZSCAN4-DEPENDENT GENES FOR DIRECT REPROGRAMMING OF SOMATIC CELLS EP National Stage 12785169.9 Issued
NIA E-103-2011-2-JP-06 Use of Zscan4 and Zscan4-dependent genes for direct reprogramming of somatic cells JP National Stage 2014-510518 Issued
NIA E-103-2011-2-AU-03 Use of Zscan4 and Zscan4-dependent genes for direct reprogramming of somatic cells AU National Stage 2012256014 Issued